KEGG   DRUG: Beremagene geperpavec
Entry
D12632                      Drug                                   
Name
Beremagene geperpavec (USAN/INN);
Vyjuvek (TN)
Product
VYJUVEK (Krystal Biotech)
Remark
ATC code: D03AX16
Product: D12632<US>
Efficacy
Dystrophic epidermolysis bullosa treatment
  Disease
Dystrophic epidermolysis bullosa (COL7A1 mutation) [DS:H00587]
  Type
Gene therapy product
Comment
Treatment of epidermolysis bullosa dystrophica
Target
COL7A1 [HSA:1294] [KO:K16628]
  Pathway
hsa04974  Protein digestion and absorption
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 D DERMATOLOGICALS
  D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
   D03A CICATRIZANTS
    D03AX Other cicatrizants
     D03AX16 Beremagene geperpavec
      D12632  Beremagene geperpavec (USAN/INN) <US>
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Organismal systems
   Digestive system
    COL7A1
     D12632  Beremagene geperpavec (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
 Cellular and gene therapy products
  D12632
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12632
Other DBs
CAS: 2241888-62-8
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system